Business, Management, Marketing, Money, Tax, Law, People

Singapore – September 29, 2025 – Cooley advised Full-Life Technologies, a fully integrated global radiotherapeutics company, on its $77 million Series C financing. This financing will advance development of Full-Life’s radiopharmaceutical pipeline worldwide and manufacturing capabilities in Belgium.  Junson Capital led the financing, with new investors Lapam Capital, Plaisance, TruMed Investment and other prestigious investors, as well as participation from existing shareholders Gordian Ventures, HSG, Prosperity7, Summer Capital and other…

Palo Alto – October 8, 2025 – Cooley advised InnoCare Pharma, a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing first-in-class and best-in-class drugs for the treatment of cancers and autoimmune diseases with unmet medical needs in China and worldwide, on its transformational license agreement with Zenas BioPharma, granting Zenas global development and commercialization rights to orelabrutinib for multiple sclerosis and across all therapeutic areas other than oncology. Under…

Palo Alto – October 13, 2025 – Cooley partner John Bostic was inducted into the American College of Trial Lawyers (ACTL) during the organization’s national meeting on October 11. Founded in 1950, the ACTL is widely considered the premier professional trial organization in North America. Its membership comprises the best of the trial bar from the United States and Canada. Fellowship in the college is extended by invitation only –…

On 10 September 2025, the UK’s Office of Financial Sanctions Implementation (OFSI) issued a notice imposing a 152,750-pound penalty on Colorcon Limited, a UK-registered company. A global provider of pharmaceutical and nutritional supplies, Colorcon had been operating in Russia for nearly 15 years before the company’s eventual exit from the country in August 2022. OFSI’s penalty decision was made in response to the company’s breach of Russia (Sanctions) (EU Exit)…